Jaw clenching (bruxism) associated with stimulant use
Jaw clenching associated with stimulant (amphetamine/dextroamphetamine) use is managed by reducing the precipitating factor when feasible and by providing symptom-directed treatment to protect teeth and reduce myofascial jaw pain.
Medication adjustment for stimulant-associated clenching
A medication-related contribution is recognized because some ADHD medicines may increase the chances of bruxism.
Clinical medication strategies used in practice include:
- Dose reduction of the stimulant and reassessment of clenching intensity after changes in dosing or timing.
- Switching to an alternative ADHD pharmacotherapy when symptoms persist despite dose optimization.
Dental protection and stabilization appliances
Intraoral appliances are recommended to protect teeth from the destructive effects of clenching and grinding.
Options include:
- Mouth guards or splints that separate the upper and lower teeth during clenching episodes.
- Dental appliances as part of dental treatment planning when jaw symptoms or tooth wear indicate bruxism-related damage.
Behavioral and neuromuscular approaches
Behavioral strategies are recommended to reduce clenching habits and to reduce stress-related jaw muscle activity. (ncbi.nlm.nih.gov)
Common nonpharmacologic options used for symptomatic clenching include:
- Stress management and relaxation practices.
- Behavior change strategies that increase awareness of daytime clenching and practice correct mouth and jaw position.
- Jaw exercises, stretching, massage, and heat or cold application for symptomatic jaw muscles. (ncbi.nlm.nih.gov)
Chronic myofascial pain care for temporomandibular disorder phenotype
When jaw clenching presents with temporomandibular disorder (TMD) pain features, initial care is typically conservative. (ncbi.nlm.nih.gov)
Conservative TMD options supported in clinical guidance include:
- Soft diet and avoidance of aggravating activities during flares. (annalidistomatologia.eu)
- Heat or cold, jaw exercises, and massage. (annalidistomatologia.eu)
- Short-term NSAIDs for pain control. (annalidistomatologia.eu)
- Cognitive behavioral therapy with or without biofeedback or relaxation therapy. (ncbi.nlm.nih.gov)
Pharmacologic options for symptomatic periods
Medication selection is symptom-directed and is generally used short-term for jaw pain or severe episodes. (annalidistomatologia.eu)
Options used in practice include:
- Short-term muscle relaxant use for selected patients with severe bruxism-related symptoms.
- Neuromodulatory medications for chronic TMD pain syndromes in guideline-based care pathways. (annalidistomatologia.eu)
- Treatment of comorbid stress, anxiety, or other medical conditions when those contributors are present.
Interventional options when conservative therapy fails
Botulinum toxin injections and reversible occlusal splints are not preferred for chronic TMD pain because clinical practice guidance includes conditional recommendations against reversible occlusal splints (alone or in combination with other interventions) and conditional recommendations against botulinum toxin for specific chronic TMD pain contexts. (ncbi.nlm.nih.gov)
Interventional care is reserved for selected refractory cases and is typically delivered via TMD-focused dental or oral surgery pathways. (annalidistomatologia.eu)
Treatment targets and monitoring
Treatment aims include preventing tooth damage and reducing jaw pain and jaw muscle tiredness.
Monitoring priorities include:
- Regular dental examinations to identify and quantify tooth wear and other bruxism-related complications.
- Evaluation for sleep-related disorders when bruxism is suspected to occur during sleep.
- Reassessment after stimulant dose changes to determine whether clenching intensity decreases.